These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 32305128)
1. Mesenchymal stromal cell-based therapies for acute kidney injury: progress in the last decade. Fazekas B; Griffin MD Kidney Int; 2020 Jun; 97(6):1130-1140. PubMed ID: 32305128 [TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanisms of Mesenchymal Stem Cell-Based Therapy in Acute Kidney Injury. Lee PW; Wu BS; Yang CY; Lee OK Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768837 [TBL] [Abstract][Full Text] [Related]
3. The Beneficial Effects of Mesenchymal Stem Cells in Acute Kidney Injury: A Narrative Review. Liu Y; Han J; Fang J; Li R Curr Stem Cell Res Ther; 2024; 19(2):200-209. PubMed ID: 36748221 [TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapeutic Strategy for Acute Kidney Injury. Li JK; Yang C; Su Y; Luo JC; Luo MH; Huang DL; Tu GW; Luo Z Front Immunol; 2021; 12():684496. PubMed ID: 34149726 [TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice. Luo CJ; Zhang FJ; Zhang L; Geng YQ; Li QG; Hong Q; Fu B; Zhu F; Cui SY; Feng Z; Sun XF; Chen XM Shock; 2014 Feb; 41(2):123-9. PubMed ID: 24169208 [TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges. Aghajani Nargesi A; Lerman LO; Eirin A Stem Cell Res Ther; 2017 Dec; 8(1):273. PubMed ID: 29202871 [TBL] [Abstract][Full Text] [Related]
7. Pulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice. Burks SR; Nguyen BA; Tebebi PA; Kim SJ; Bresler MN; Ziadloo A; Street JM; Yuen PS; Star RA; Frank JA Stem Cells; 2015 Apr; 33(4):1241-53. PubMed ID: 25640064 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell therapy in acute kidney injury (AKI): review and perspectives. Sávio-Silva C; Soinski-Sousa PE; Balby-Rocha MTA; Lira ÁO; Rangel ÉB Rev Assoc Med Bras (1992); 2020 Jan; 66Suppl 1(Suppl 1):s45-s54. PubMed ID: 31939535 [TBL] [Abstract][Full Text] [Related]
9. The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury. Ranghino A; Bruno S; Bussolati B; Moggio A; Dimuccio V; Tapparo M; Biancone L; Gontero P; Frea B; Camussi G Stem Cell Res Ther; 2017 Feb; 8(1):24. PubMed ID: 28173878 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cell potency to treat acute kidney injury increased by ultrasound-activated interferon-γ/interleukin-10 axis. Burks SR; Nagle ME; Bresler MN; Kim SJ; Star RA; Frank JA J Cell Mol Med; 2018 Dec; 22(12):6015-6025. PubMed ID: 30216653 [TBL] [Abstract][Full Text] [Related]
12. Effect of combination of vitamin E and umbilical cord-derived mesenchymal stem cells on inflammation in mice with acute kidney injury. Guo Q; Wang J Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):168-172. PubMed ID: 29355065 [TBL] [Abstract][Full Text] [Related]
13. Progress toward the Clinical Application of Mesenchymal Stromal Cells and Other Disease-Modulating Regenerative Therapies: Examples from the Field of Nephrology. Hickson LJ; Herrmann SM; McNicholas BA; Griffin MD Kidney360; 2021 Mar; 2(3):542-557. PubMed ID: 34316720 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the treatment efficacy of umbilical mesenchymal stem cell transplantation via renal subcapsular and parenchymal routes in AKI-CKD mice. Huang M; Li D; Chen J; Ji Y; Su T; Chen Y; Zhang Y; Wang Y; Li F; Chen S; Dong Y; Li Q; Wu L; Feng Z; Wu J; Zhang L; Li Z; Cai G; Chen X Stem Cell Res Ther; 2022 Mar; 13(1):128. PubMed ID: 35337372 [TBL] [Abstract][Full Text] [Related]
15. Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: a review with a focus on preclinical models. Zhao L; Han F; Wang J; Chen J Stem Cell Res Ther; 2019 Dec; 10(1):385. PubMed ID: 31843011 [TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory Effects of Mesenchymal Stem Cells on Drug-Induced Acute Kidney Injury. Han Q; Wang X; Ding X; He J; Cai G; Zhu H Front Immunol; 2021; 12():683003. PubMed ID: 34149721 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stem Cells: a Promising Therapeutic Tool for Acute Kidney Injury. Selim RE; Ahmed HH; Abd-Allah SH; Sabry GM; Hassan RE; Khalil WKB; Abouhashem NS Appl Biochem Biotechnol; 2019 Sep; 189(1):284-304. PubMed ID: 30976980 [TBL] [Abstract][Full Text] [Related]
18. Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury. Zilberman-Itskovich S; Abu-Hamad R; Zarura R; Sova M; Hachmo Y; Stark M; Neuman S; Slavin S; Efrati S PLoS One; 2019; 14(9):e0222354. PubMed ID: 31513644 [TBL] [Abstract][Full Text] [Related]
19. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway. Bai M; Zhang L; Fu B; Bai J; Zhang Y; Cai G; Bai X; Feng Z; Sun S; Chen X Kidney Int; 2018 Apr; 93(4):814-825. PubMed ID: 29132705 [TBL] [Abstract][Full Text] [Related]
20. Optimization strategies of mesenchymal stem cell-based therapy for acute kidney injury. Fu Z; Zhang Y; Geng X; Chi K; Liu C; Song C; Cai G; Chen X; Hong Q Stem Cell Res Ther; 2023 Apr; 14(1):116. PubMed ID: 37122024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]